Get SEC filing alerts via email and in your feed for Pluri Inc.
PLUR
Pluri Inc.
About Pluri Inc.
Pluri Inc. is a biotechnology company specializing in proprietary 3D cell expansion technology for scalable solutions across healthcare, food, and agriculture. Its core activities include developing cell therapies, regenerative medicine, cultivated food products, and contract manufacturing services. The company leverages its innovative platform for cell-based therapeutics, food tech, and AgTech, serving global markets with a focus on sustainability, cost-efficiency, and advanced bioprocessing.
This description was generated via AI from an annual report.
Updated 8 months ago.